You are here

Factor XI inhibitor

Anthos doubles down on its novel blood thinner

EP Vantage

Fri, 01/27/23 - 10:34 am

Factor XI inhibitor

FDA grants fast track designation for Anthos’ cancer associated thrombosis therapy

Pharmaceutical Business Review

Mon, 07/11/22 - 10:26 am

Anthos Therapeutics

Factor XI inhibitor

The 3 Biggest Biotech Wins of the Week

Motley Fool

Wed, 05/28/14 - 10:52 am

Gilead Sciences

Factor XI inhibitor

Isis Pharmaceuticals